Skip to main content
TipRanks
Go Ultimate75% OFF

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Stock Statistics & Valuation Metrics

2 Followers

Total Valuation

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H has a market cap or net worth of HKD 14.27B. The enterprise value is HKD 4.32B.

Market Cap
HKD 14.27B
Enterprise Value
HKD 4.32B

Share Statistics

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H has 220,094,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
220,094,500
Owned by Insiders
―
Owned by Institutions
0.98%

Financial Efficiency

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 3.75%.

Return on Equity (ROE)
0.03
Return on Assets (ROA)
0.02
Return on Invested Capital (ROIC)
3.75%
Return on Capital Employed (ROCE)
0.05
Revenue Per Employee
2.55M
Profits Per Employee
162.55K
Employee Count
2,150
Asset Turnover
0.33
Inventory Turnover
0.84

Valuation Ratios

The current PE Ratio of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H is 69.83. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H’s PEG ratio is -1.27.

PE Ratio
69.83
PS Ratio
2.39
PB Ratio
1.11
Price to FCF
6.58
Price to Operating Cash Flow
6.87
PEG Ratio
-1.27

Income Statement

In the last 12 months, Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H had revenue of 5.48B and earned 349.49M in profits. Earnings per share was 0.24.

Revenue
5.48B
Gross Profit
1.74B
Operating Income
635.97M
Pretax Income
402.24M
Net Income
349.49M
EBITDA
846.59M
Earnings Per Share (EPS)
0.24

Cash Flow

In the last 12 months, operating cash flow was 1.77B and capital expenditures -105.55M, giving a free cash flow of 1.67B billion.

Operating Cash Flow
1.77B
Free Cash Flow
1.67B
Free Cash Flow per Share
1.26

Dividends & Yields

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H pays an annual dividend of HKD 0.27, resulting in a dividend yield of 4.13%

Dividend Per Share
HKD 0.27
Dividend Yield
4.13%
Payout Ratio
86.79%
Free Cash Flow Yield
15.19%
Earnings Yield
1.42%

Stock Price Statistics

Beta
0.71
52-Week Price Change
-29.47%
50-Day Moving Average
3.98
200-Day Moving Average
4.39
Relative Strength Index (RSI)
53.20
Average Volume (3m)
535.50K

Important Dates

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 29, 2026
Next Earnings Date
Apr 01, 2027
Ex-Dividend Date
May 26, 2025

Financial Position

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H as a current ratio of 2.31, with Debt / Equity ratio of 17.53%

Current Ratio
2.31
Quick Ratio
1.19
Debt to Market Cap
0.30
Net Debt to EBITDA
0.90
Interest Coverage Ratio
8.90

Taxes

In the past 12 months, Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H has paid 59.60M in taxes.

Income Tax
59.60M
Effective Tax Rate
0.15

Enterprise Valuation

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H EV to EBITDA ratio is 29.73, with an EV/FCF ratio of 7.35.

EV to Sales
2.66
EV to EBITDA
29.73
EV to Free Cash Flow
7.35
EV to Operating Cash Flow
6.95

Balance Sheet

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H has HKD 4.27B in cash and marketable securities with HKD 2.86B in debt, giving a net cash position of HKD 1.41B billion.

Cash & Marketable Securities
HKD 4.27B
Total Debt
HKD 2.86B
Net Cash
HKD 1.41B
Net Cash Per Share
HKD 6.40
Tangible Book Value Per Share
HKD 6.55

Margins

Gross margin is 33.50%, with operating margin of 8.91%, and net profit margin of 3.74%.

Gross Margin
33.50%
Operating Margin
8.91%
Pretax Margin
3.33%
Net Profit Margin
3.74%
EBITDA Margin
8.96%
EBIT Margin
5.14%

Analyst Forecast

The average price target for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-1.32%
EPS Growth Forecast
-50.00%

Scores

Smart Score
4
AI Score
56